THRX

Theseus Pharmaceuticals, Inc. Common Stock
THRX

Overview Fund Activity
Delisted

THRX was delisted on the 13th of February, 2024.

Back to rankings

47 hedge funds and large institutions have $403M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+1
Holders Change %
+2.17%
% of All Funds
0.74%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
5
Increased
12
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
OrbiMed
New York
+$2.34M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.56M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.25M
4
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$701K
5
State Street
State Street
Massachusetts
+$644K

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.82M
2
LCM
Lynx1 Capital Management
Puerto Rico
-$606K
3
LCM
Laurion Capital Management
New York
-$293K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$281K
5
DCM
DAFNA Capital Management
California
-$200K
Name Holding Trade Value Shares
Change 		Shares
Change %
AGM
51
Alpine Global Management
New York
– -$144K -11,340 Closed
1 2
3